Life is a health journey that for some starts by being born with a rare genetic disorder. There are more than 7,000 rare diseases in the world, and 30% of children affected die before reaching their 5th birthday.

Sanofi Genzyme

Photo of 5 kids sitting on a bench

Sanofi Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Sanofi Genzyme focuses on educating Health Care Professionals regarding the diagnosis, screening and management of the diseases we provide treatment for.

Our objectives are to ensure accurate diagnosis of the diseases we help doctors to treat and to raise awareness of the diseases with doctors, other Health Care Professionals, patient organisations and the public.

Sanofi Genzyme always endeavours to provide a high standard of service to both treating doctors and their patients. Our dedication to patients extends beyond the development of products. We've initiated numerous free drug and humanitarian programs to ensure that vital treatment reaches all those who need it.

At Sanofi Genzyme we recognise the need for patients to have access to ongoing support. We have therefore worked with the South African patient organisation to ensure that patients have people to turn to for help and emotional support. The patient organisation can put them into contact with one another so that they can share their experiences and support each other.

We strive to deliver optimal treatment and reimbursement assistance for the following Lysosomal Storage Disorders: Gaucher, Pompe, MPS 1, & Fabry disease as well a drug that is used to monitor patients with thyroid cancer.